Publication | Open Access

Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience

OncologyMedicineSingle-center ExperienceFirst-line TreatmentPharmacotherapyCarboplatin RegimenAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyLung Cancer